Zeydovio

Beyond's analysis on Zeydovio

• 2026-09-18 — Zealand Pharma secures major regulatory milestone with positive CHMP opinion for Zeydovio in short bowel syndrome treatment

Recent news mentioning Zeydovio

• 2026-09-18 — Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

Appears alongside

• Zealand Pharma
• CHMP

Browse the full archive →